Sec61β Controls Sensitivity to Platinum-Containing Chemotherapeutic Agents through Modulation of the Copper-Transporting ATPase ATP7A
Paolo Abada(Eli Lilly (United States)), Stephen B. Howell(Ames Research Center)
Cited by 15
Related Papers
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
|Liver International|2019|591
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
|Molecular Pharmacology|2010|340
Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients
|Head & Neck|2000|213
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2023|213
The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
|Molecular Pharmacology|2008|181